izpis_h1_title_alt

Extracellular cystatin F is internalised by cytotoxic T lymphocytes and decreases their cytotoxicity
ID Prunk, Mateja (Avtor), ID Perišić, Milica (Avtor), ID Jakoš, Tanja (Avtor), ID Sabotič, Jerica (Avtor), ID Švajger, Urban (Avtor), ID Kos, Janko (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (3,56 MB)
MD5: B5FCEA90FFA7037B47AD076461BC3B0C
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2072-6694/12/12/3660 Povezava se odpre v novem oknu

Izvleček
Cystatin F is a protein inhibitor of cysteine cathepsins, peptidases involved in the activation of the effector molecules of the perforin/granzyme pathway. Cystatin F was previously shown to regulate natural killer cell cytotoxicity. Here, we show that extracellular cystatin F has a role in regulating the killing efficiency of cytotoxic T lymphocytes (CTLs). Extracellular cystatin F was internalised into TALL-104 cells, a cytotoxic T cell line, and decreased their cathepsin C and H activity. Correspondingly, granzyme A and B activity was also decreased and, most importantly, the killing efficiency of TALL-104 cells as well as primary human CTLs was reduced. The N-terminally truncated form of cystatin F, which can directly inhibit cathepsin C (unlike the full-length form), was more effective than the full-length inhibitor. Furthermore, cystatin F decreased cathepsin L activity, which, however, did not affect perforin processing. Cystatin F derived from K-562 target cells could also decrease the cytotoxicity of TALL-104 cells. These results clearly show that, by inhibiting cysteine cathepsin proteolytic activity, extracellular cystatin F can decrease the cytotoxicity of CTLs and thus compromise their function.

Jezik:Angleški jezik
Ključne besede:cystatin F, cathepsins, cytotoxic lymphocytes, granzymes, perforin, TALL-104
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2020
Št. strani:14 str.
Številčenje:Vol. 12, iss. 12, art. 3660
PID:20.500.12556/RUL-134854 Povezava se odpre v novem oknu
UDK:616.1
ISSN pri članku:2072-6694
DOI:10.3390/cancers12123660 Povezava se odpre v novem oknu
COBISS.SI-ID:43955203 Povezava se odpre v novem oknu
Datum objave v RUL:04.02.2022
Število ogledov:653
Število prenosov:109
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Cancers
Skrajšan naslov:Cancers
Založnik:MDPI
ISSN:2072-6694
COBISS.SI-ID:517914137 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:06.12.2020

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:cistatin F, katepsini, citotoksični limfociti

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:J4-1776
Naslov:Izboljšanje imunoterapevtske vrednosti NK celic z modulacijo cistatina F

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P4-0127
Naslov:Farmacevtska biotehnologija: znanost za zdravje

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj